vimarsana.com

Page 154 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biotech Startup Triveni Unveils $92M to Address Barrier to Treating Inflammation

Available atopic dermatitis drugs work by blocking inflammation, but Triveni Bio is developing an antibody that addresses a root cause of the chronic condition. The startup is out of stealth to advance its lead program and a pipeline of other inflammation and immunology drugs.

Mitchell Berger, Author at MedCity News

Mitchell Berger, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Unlocking the Power of Healthcare Audiences: Segmenting Stakeholders and Maximizing Impact

This article delves into the importance of audience segmentation, offers guidance on identifying distinct audience groups, and discusses influential personas in healthcare.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.